Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/15/2025

Finasteride Therapy

Introduction to Finasteride

  • Finasteride commonly causes sexual side effects including decreased libido, ejaculatory dysfunction, and erectile dysfunction, which are reversible upon discontinuation but may persist in some patients after stopping the medication 1

Efficacy and Safety

  • Finasteride reduces serum PSA levels by approximately 50% after 12 months of therapy, which is clinically important because PSA levels must be doubled when screening for prostate cancer in men taking finasteride 2
  • Finasteride reduces serum PSA levels by approximately 50% after 12 months of therapy, which is clinically important because failure to account for this reduction could mask the detection of prostate cancer 3
  • Most side effects are reversible upon discontinuation 1
  • However, post-finasteride syndrome has been reported - a controversial condition involving persistent sexual, physical, and psychological symptoms after stopping the medication 4
  • The FDA has added a warning about potential persistent sexual side effects to the drug label, though the evidence is based primarily on anecdotal reports rather than prospective trials 4

Special Considerations

  • In geriatric patients, carefully weigh medication burden against benefits, as side effects may have greater impact on quality of life 5

Monitoring and Patient Education

  • Discuss potential side effects with patients before initiating therapy, including the risk of persistent sexual dysfunction, and monitor for sexual dysfunction, breast changes, and mood alterations 4